Rapid reduction in Staphylococcus aureus in atopic dermatitis subjects following dupilumab treatment
Eric L. Simpson(Oregon Health & Science University), Lisa A. Beck(University of Rochester Medicine), Justin Ko(Stanford University), Donald Y.M. Leung(Boston Children's Hospital), Samuel H. Kilgore(University of Iowa), Amanda K. Rudman Spergel(Moderna Therapeutics (United States)), Steven R. Gill(University of Rochester Medical Center), Mark Boguniewicz(University of Colorado Denver), Liam F. Peterson(University of Rochester), Anna De Benedetto(University of Rochester Medicine), Stephanie Lussier(Buck Institute for Research on Aging), Zelma C. Chiesa Fuxench(University of Pennsylvania), Marshall Plaut(National Institutes of Health), Takeshi Yoshida(Kanazawa University), Tim R. Mosmann(National Institutes of Health), Patrick M. Schlievert(University of Iowa), Sally A. Quataert(University of Rochester), Ann Gill(University of Rochester Medical Center), Tissa Hata(University of California San Diego), Agustin Calatroni(Johns Hopkins University), Gloria L. David(Rho (United States)), Peck Y. Ong(Children's Hospital of Los Angeles)
Cited by 93
Related Papers
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report
|Journal of Allergy and Clinical Immunology|2010|2.3k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2.1k
Atopic dermatitis
|Nature Reviews Disease Primers|2018|1.5k